Investigación traslacional en microbioma (InTraMic): un área de interés común y creciente en el IMTIB, Hospital Italiano e Instituto Universitario

Vaccaro, Carlos Alberto; Pavicic, Walter; Gadano, Adrián; Risk, Marcelo; Figari, Marcelo; Llesuy, Susana; Piñero, Tamara; Trinks, Julieta; Burgos, Valeria; Mazzini, Flavia; Arbelbide, Jorge; Basquiera, Ana; Bolontrade, Marcela; Giménez, María Isabel; Jauk, Federico; Argüero, Julieta.
Rev. Hosp. Ital. B. Aires (2004) ; 40(1): 17-24, mar. 2020. ilus
Artículo en Español | LILACS | ID: biblio-1100762

Documentos relacionados

  1. Microbiota-Liver Diseases Interactions.
  2. Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
  3. NON-ALCOHOLIC FATTY LIVER DISEASE IN THE CONTEXT OF ALTERED GUT MICROBIOTA.
  4. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases.
  5. Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets.
  6. Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway.
  7. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease.
  8. [Modulation of the intestinal microbiota by nutritional interventions].
  9. Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults.
  10. Association between the severity of metabolic dysfunction-associated fatty liver disease and the risk of colorectal neoplasm: a systematic review and meta-analysis.